Welcome to the Journal


Journal of Leukaemia & Lymphoma Research is an open access scholarly journal that publishes peer reviewed scientific manuscripts on current trends in oncology medicine as well as ground breaking research developments on the diagnosis and treatment of blood cancer and bone marrow defects. The journal wishes to publish research manuscripts that will contribute to oncological research with special reference to the oncological complications of blood cells.

The scope of the journal incorporates high end research outputs pertaining to the prevention, timely detection and subsequent treatment of haematopoietic oncological disorders viz. acute and chronic myeloid leukemia, acute and chronic lymphocytic leukemia, hairy cell leukemia, chronic myelomonocytic leukemia, juvenile myelomonocytic leukemia, large granular leukemia and lymphocytic leukemia.

The journal also publishes articles that showcase novel insights into the molecular mechanism of DNA mutations, genetic changes and clonal evolution of tumorigenic haematopoietic cells. Manuscripts on physiological and molecular intricacies involved in the management of swollen lymph nodes, anaemia and other oncological blood disorders are solicited for publication. The Journal of Leukaemia & Lymphoma Research aspires to provide a platform for the researchers and oncologists all over the globe to exchange valuable scientific and clinical information, which will help in the innovation of clinically relevant diagnostic as well as therapeutic tools and techniques.

*2023 Journal Impact Factor was established by dividing the number of articles published in 2021 and 2022 with the number of times they are cited in 2023 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2021 and 2022, and 'Y' is the number of times these articles were cited in indexed journals during 2023 then, journal impact factor = Y/X